Xeris Biopharma Holdings Inc. buy HC Wainwright
Start price
15.08.24
/
50%
€2.37
Target price
15.08.25
€5.47
Performance (%)
8.52%
Price
16.09.24
€2.57
Summary
This prediction is currently active. With a performance of 8.52%, the BUY prediction by HC_Wainwright for Xeris Biopharma Holdings Inc. is trending in the right direction. This prediction currently runs until 15.08.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Xeris Biopharma Holdings Inc. | 4.549% | 4.549% |
iShares Core DAX® | 1.887% | 1.967% |
iShares Nasdaq 100 | 2.316% | -1.227% |
iShares Nikkei 225® | 1.134% | 0.390% |
iShares S&P 500 | 1.821% | 0.790% |
Comments by HC_Wainwright for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by HC_Wainwright for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.11
31.05.24
31.05.24
€5.51
31.05.25
31.05.25
21.88%
16.09.24
16.09.24
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.16
10.08.23
10.08.23
€5.44
10.08.24
10.08.24
-0.46%
11.08.24
11.08.24
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€1.15
09.03.23
09.03.23
€5.67
09.03.24
09.03.24
91.14%
10.03.24
10.03.24